Global payer evidence manager

Department : GBS , Commercial and Corporate Affairs (CSCA) Do you want to work for an organization that has a strong purpose towards driving change to defeat diabetes and serious chronic diseases such as NASH and Cardiovascular, rare blood and rare endocrine diseases? If so, you could be the right person to join our Commercial and Corporate Affairs team. Apply today and join us for a life:changing career. About the department The Commercial and Corporate Affairs : Global Business Services (GBS) unitis responsible for driving deliverables for multiple Corporate Vice President (CVP) areas within Commercial Strategy and Corporate Affairs, including Insulin, GLP:1 and ObesityMarketing, Market Access, Commercial Planning and Commercial Operations. In the market access area, we are a passionate team helping millions of people across multiple TAs, gain access to life saving innovative solutions and technologies developed by Novo Nordisk. We work to ensure our products have a global reach to as many people as possible at right price at the earliest. We drive and execute projects across a strong portfolio comprising of both launch and life:cycle management brands. The Position Support market access preparedness by generating insights from real world data, by designing and executing highly robust payer relevant real world evidence studies leveraging commercial and open:source real world data sources. Generate robust real:world evidence (RWE) to support market access activities pre/during and post launch. The studies include but not limited to epidemiologic analysis like incidence and prevalence, healthcare resource cost and utilization, adherence, persistence analysis. Independently drive execution of end:to:end real:world evidence generation studies. Proactive planning of project milestones and ensure projects are delivered as per timeline. Statistical programming and input to analysis plan. Provide guidance for PEG Mangers in HQ about real:world data sources, strengths and limitations. Provide recommendations on additions to study objectives/inputs during study design. Establish strong collaboration with DK colleagues/affiliates. Sparring partner to DK team/affiliates/region/business area to generate impactful evidence. : Design study analysis plan and Execute feasibility analysis then advice on conduct of full studies. : Data and statistical programming/writing code scripts (SQL, SAS/R). : Provide support for publication materials across key major international/national congresses by participating in the author reviews. : Prepare analyses cohorts based on in:house commercial EMR/claims databases. Develop analyses approaches and procedures in commercial databases for recurrent analyses. Interpretation of output and provides suggestions on improvements. : Participate and drive update discussions with the Global PEG team and internal knowledge sharing discussions. Participate in internal team and strategy meetings within NN GBS and HQ. Also, be a buddy for new joiners in the team. Qualification : Bachelor s degree in Pharma (BPharm), Science/Biotechnology (BSc), Engineering (BTech). Master s degree in Biostatistics, Mathematics, Economics, Engineering, Computer science, Life sciences, public health or equivalent will be preferred. : Documented Experience with biostatistics /econometrical methods and application : Minimum of 4 to 8 years of experience in data analytics/science, ideally within pharmaceutical industry. : Minimum 3 to 5 years working on analysing RWD from insurance claims or hospital records across geographies. : Experience contributing to medical publications preferred. : Communication and Stakeholder interaction. Working at Novo Nordisk Novo Nordisk is its people. We know that life is anything but linear and balancing what is important at different stages of our career is never easy. That s why we make room for diverse life situati